UroGen Pharma (UR8.F) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.9
-0.77
-0.64
-0.5

Details

Expected EPS
-0.74991664539
Actual EPS
-0.5047515
Surprise EPS
0.25
Surprise Percent
+32.69%

Description

UroGen Pharma (UR8.F) has reported earnings of -0.5047515 per share for Q4 2024.

0 Comments

Share your thoughts